Discussion
Many governments and international organisations relied substantially on emerging evidence for evidence-based or evidence-informed policymaking during the COVID-19 pandemic revealing the importance of policy advice based on sound science. Our findings are compatible with the literature on EBPM in the COVID-19 pandemic,17 18 however we note that the amount of evidence presented in support of policymaking varied in the targeted phase of the policymaking process (policy cycle focus) and type of evidence.
Purpose of evidence including policy cycle focus
Pandemic surveillance, response and control strategies gained more traction with an abundance of evidence compared with prevention and recovery strategies in our study (figure 2). This has large public health implications on the way evidence is selected and used for policymaking. With WHO announcing on 5 May 2023, that COVID-19 is no longer a public health emergency of international concern (PHEIC),19 20 the global community is gradually transitioning from a pandemic to an endemic stage of COVID-19 with several countries applying various recovery strategies.21 The decision regarding transition to a non-PHEIC was based on declining COVID-19 deaths, hospitalisations and ICU admissions and on high levels of population immunity from vaccination and previous infections.19 Nonetheless, caution should be applied in the recommendations for the long-term management of the pandemic, acknowledging that risks remain high and that there are uncertainties in the evolution of the virus and our responses.
Unfortunately, our findings also revealed a paucity of evidence in support of recovery strategies with only four articles presenting evidence for community impacts, stabilisation and the economic recovery processes.22–25 We do take into consideration that the time constraints on our search (2020–2022) means that more recent research on recovery, drafted and published after the WHO’s announcement, are not included in our dataset. The short and long-term effects of COVID-19 pandemic response measures on health systems, commerce, education and employment are crucial, especially for economically vulnerable countries.24 For a successful recovery from the COVID-19 pandemic, some researchers have advocated for nations to adopt evidence-based frameworks to ensure community stabilisation and sustainability. Additional evidence will provide support for the prevention of the emergence and spread of pandemic-prone diseases including possible animal-vector management. Unfortunately, only a few of the articles reported on the unintended impact of COVID-19 policies and mitigation measures on the quality of life of the general public26–29 or articulated measures to support the improvement, planning and activation of public health control measures for the prevention of future pandemic.30–35 Key behavioural risk factors can be targeted for the development of strategies to reduce the threat of novel zoonotic diseases.35 Preparedness ensures that some thought and resources are devoted to generating the knowledge and materials needed to respond to and recover from a disaster or epidemic that has occurred.
Although all papers mentioned evidence-based or evidence-informed policy, many of the articles only did so peripherally. The purpose of over 60% of papers was to present research findings without a clear discussion of the research in the context of an existing policy, its impact or a policy need (figure 2). This could suggest several things. First, ‘evidence-based’ and ‘evidence-informed’ policies are catchphrases that are used to increase impact but are not often explained or understood. Second, most evidence collected were of the type that is appropriate to be presented as findings only. Other researchers have previously commented on the fact that most research used in EBPM during the pandemic was biomedicine centric.36 37 As such, it is possible that this type of research was explicitly encouraged, and that research on understanding policy implications, discussions of policy effects and the process of EBPM itself was considered less relevant or not given due consideration. This may also be a result of the types of questions that policymakers did or did not ask.37 38 Nevertheless, our current result could simply be a matter of timing, with fast evidence production at the start of the pandemic not being amenable to exploring in-depth implications for policies. Zaki and Wayenberg39 posit that wicked crisis like COVID-19 pandemic can compromise the quality of epistemic policy learning and offered simplified exploratory analytical framework to assist policymakers to manage the integration of scientific knowledge into policy responses within wicked crisis contexts. The framework provided a potential structure to assist policymakers in assessing the inclusiveness of policy learning during wicked crisis and accommodates for cross-case comparisons while ensuring interdisciplinarity and multiplicity of perspectives. This approach has a potential to improve policymakers’ ability to use scientific advice in policy formulation and public communication taking into consideration the uncertainty of emerging knowledge.
Policy-level focus/type of evidence
The majority of the evidence in our study focused on operational policies, including management strategies, regulations and action or implementation plans to tackle the pandemic. Only a few of the articles mentioned legislation as a policy process relevant to the pandemic.28 30 37 40–50 However, experience has shown that targeting legislation with the involvement of members of parliaments, selected citizens and scientists in evidence-based decision-making will ensure sustainability and improve the value acceptability of measures as well as their technical and financial feasibility.51
The high number of systematic reviews was not surprising, as systematic reviews and meta-analysis are considered the pinnacle of evidence hierarchies in EBPM discourse.52 However, despite the number of systematic reviews, their quality and usefulness in policymaking have been questioned.53 Arguably, reconsideration needs to be given to the propagation of systematic reviews for EBPM, and as Yang54 points out, this is particularly so in an emergency where ‘the evidentiary standard of EBPM needs to be adjusted’ to include, at the least, the informed judgement of medical professionals and other seasoned experts in the absence of clinical trials and other types of evidence commonly considered as ‘appropriate’.55 56
Developing/developed economy disparities and OA availability
Evidence continues to be predominantly produced by developed countries as depicted from our mapping (figure 4). This data are comparable with recent statistics that show that the leading producers of scientific research outputs are the USA, China, the UK and Germany, with a noticeable absence of South American and African countries in the top 10.57 This disparity mirrors the Global North/Global South dialogue (with exception of Australia and New Zealand). This is also in line with larger discussions on epistemic injustice and whose knowledge should count in emergencies like the COVID-19 pandemic.36 Equity and equality in the treatment of groups and regions in knowledge-related and communication practices have been a topic of discussion with some authors advocating for action-oriented framework of epistemic justice in healthcare, information science and education for sustainable development.36 58 59 It is clear that, building resilience and preparedness for future crisis would require strategies that embrace greater pluralism and above all addresses the inter-related inequalities through exploration of alternative social structures and facilitated by modern technological solutions.36 In this study, authors from developing countries were apparently more willing to engage in intersectoral and intercountry collaboration than their counterparts from developed economy. Interdisciplinarity and multicountry collaborations in crucial as it promotes credibility within the institutions of science advice, and this ensures robust policy options with greater inclusivity and a clear understanding of the impacts of policies especially on the most disadvantaged in the society.
Most of the evidence (93.4%) included in this study was available by OA and, therefore, accessible to policymakers directly or to knowledge brokers who can then transmit evidence to policymakers. In our research, material from lead authors from developing countries were available at similar OA proportions to lead authors from developed economies, however the type of OA varied. Open accessibility, however, continues to be a subject of debate due to the (lead) author-based funding requirement, with attention being drawn to the need to ensure that the knowledge gap between the developing/developed economies is bridged. A recent white paper examined the challenges of OA publication in lower and middle-income countries (LMIC) and how the playing field can be levelled to permit knowledge/evidence produced in LMICs to find a wider audience.60 The paper identified some practical options/ways of providing support for researchers in LMICs including their involvement in editorial boards and the peer review system; targeted capacity-building programmes for authors, reviewers and editors from LMIC, greater consistency and transparency around article processing charge waivers and support for the publication of research among others.60 These suggestions if adopted collectively will enhance the chances of researchers from LMICs, to achieve their OA publishing ambitions.
Our study also revealed a low level of intersectoral engagement in evidence generation with 150 articles having authorship from a single sector (online supplemental table 1). The overwhelming contribution of academics to publications observed in this study (144) highlights the concerning lack of engagement with knowledge dissemination by other sectors, potentially resulting from professional performance drivers and reward in various sectors or from deep-rooted publication biases. An effective global response to tackle public health emergencies must coordinate efforts across disciplines and backgrounds.
Policy challenges
The most frequent author-identified challenges in pandemic policymaking were ‘process failure’ and ‘poor evidence’ (including failures of epistemic due care). Based on the fast unfolding of the pandemic and the uncertainty associated with the consequences of the pandemic and measures to be developed, stated challenges and problems linked to the quality of evidence61–79 are germane. The quantity and quality of data generated and the evidence available in a crisis like the COVID-19 pandemic are usually limited and decision-makers must make important decisions quickly. Some authors have argued that evidence utilisation in public health emergencies may seem to be reduced especially if there is a lack of administrative accountability.80 This could explain why some of the authors stated a perception of failures in the uptake and consideration of evidence (process failure).25 44 45 49 61 74 81–95 Nevertheless, the majority of articles did not state any challenges concerning evidence uptake by policymakers, while 41 articles stated policy successes with apparent author satisfaction with the process of evidence uptake by policymakers. A small minority, however, raised issues of biases in the acquisition and consideration of evidence.45 63 67 91 96 97 This might have resulted from the fact that the urgency of the pandemic response required policymakers to engage with scientists and so scientists more often felt that their outputs were recognised and used for policy formulation. This can be contrasted with the EBPM process in other public health issues where there is a perceived lack of urgency.98 The risk of biases and errors in policy decision-making processes has the potential to cause widespread societal damages in a crisis context like COVID-19 pandemic. Some of the response strategies adopted during the pandemic were marred by perception of political influence on information management and bias in the selection and utilisation of evidence for decision-making for activities such as lockdown/movement restriction91 and school reopening97 despite available scientific guidance and practical evidence-based advice on how to manage infection risks. Analysis of COVID-19 lockdown strategy in five European nations identified the strengths and weakness of the process and revealed that while some nations reacted quickly and effectively, some others were flawed by their responses being slow, inconsistent and riddled with U-turns.91 Some of the authors identified information processing errors including failure to share updated information and/or revise and update conclusions and policies in the light of new information45; failure to take adequate account of scientific evidence44; lack of attention towards the nuances of sex/gender disparities within minority population61 and lack of transparency and accountability at local, national and international levels.49 It is, therefore, important that policymakers take steps to maximise the quality of the decision-making process to increase the chances of positive outcomes.
Our study extracted the residual questions and areas for future research prioritisation or policy setting, noted by the authors themselves. Understandably, there was a higher focus on questions addressing societal/public health issues around COVID-19 including impact, behavioural and implementation strategies. However, few questions sought to address issues around economic and financial sustainability or technological advancements with the potential to tackle future pandemics. A similar study by Liu et al,11 identified the ‘use of novel technologies and artificial intelligence’ as an area of COVID-19 research that remains underexplored. For instance, the need to provide access to accurate and low-cost tests for the diagnosis of COVID-19 remains a lingering challenge despite evidence that artificial intelligence and deep learning can enhance the detection and diagnosis of COVID-19.99 It could, therefore, be that the researchers are not asking the right questions or are asking questions that are skewed towards clinical management of the pandemic due to the urgency and evidence demand associated with the pandemic. Liu et al11 showed that the majority of the articles available at the onset of COVID-19 pandemic used manual statistical methods to monitor epidemiological trends as opposed to more robust and complex modelling techniques with promising public health applications.
Study limitations
This evidence map provides an overview of COVID-19 pandemic policy-relevant literature for EBPM. The authorship team had two authors independently coding at all stages and comparing the final outputs for consistency. However, we acknowledge several limitations. The search criteria/terms were designed to specifically target policy-relevant literature with ‘evidence-based’, ‘evidence-informed’ or ‘evidence-led’ policy keywords. As such, any article with no clearly stated relevance to policy was not captured irrespective of the outcome of interest. The limited literature contained in the dataset brings to the fore the need for researchers to properly articulate their policy impact statement in the research output to improve/facilitate uptake and use of evidence for relevant policymaking. This study systematically searched and synthesised COVID-19 policy-relevant evidence to identify gaps in knowledge, trends and future research needs and presented findings in a simplified way to facilitate uptake by policymakers. An in-depth qualitative analysis of synthesised evidence is not the focus of this project.
Evidence maps are not designed to assess the effectiveness of strategies or interventions. We, therefore, relied on the authors’ stated assessment/perception of policy success or failure and identified reasons for perceived policy failure. We conducted systematic searches in three databases Scopus, PubMed and LexisNexis. Therefore, some other policy-relevant literature may be available in other databases. Also, we did not consider grey literature. Another major limitation of this study is the exclusion of non-English-language articles, which led to the exclusion of 38 articles that may or may not be relevant. This was due to the limited language capacity of the team, which was mostly English speaking. This exclusion also limited our ability to make a categorical statement on the low contribution of the Global South as this may be a contributory factor.